Our research will be helpful to determine the relevance of each cancer-related signaling pathway that may be used to development of novel therapies that combine extracts of P. vulgaris with other agents including MYC, Notch, Wnt, E2F, Ets, STAT, SMAD, Hdghog, AP-1, and NF-κB blockers, to effectively treat cervical cancer, and other cancers that activate these pathways. This evidence concerns the gene NFKB1 and cervical carcinoma.